FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

NASCAR Star Kyle Busch Hospitalized with ‘Severe’ Medical Issue

Senate Republicans Deal a Serious Blow to Trump’s White House Ballroom Project

RNC legal victory clears North Carolina voter roll purge of noncitiznes through jury responses

Rep. Jim Jordan asks whether Southern Poverty Law Center paid Jan. 6 confidential sources

‘Seattle can’t survive this’: Critics hammer socialist mayor after Starbucks reversal

Zohran Mamdani announces $50 World Cup tickets for New Yorkers

Wall Street banks helped Chinese military-linked firm raise billions despite red flags, lawmakers find

Republicans recoil as Trump’s billion-dollar DOJ ‘slush fund’ for allies threatens ICE, Border Patrol plan

Manhunt underway after woman allegedly assaulted inside Harvard dorm, suspect spotted at MIT: officials

Fox News ‘Antisemitism Exposed’ Newsletter: Mamdani snubs the Jews again

‘A Day I Hoped Would Not Come’: Susie Wiles Laments as Key Official Exits White House

Netanyahu’s ‘Hair Was on Fire’ After Clashing with Trump in ‘Difficult’ Call on Latest Iran Proposal: Report

A Pastor Preached John 3:16: The Government Called It a Crime

Dem Senate Candidate Graham Platner Once Delighted in Clip of Purple Heart Veteran Being Shot and Almost Killed

Legal expert unleashes on Spanberger’s new executive order targeting ICE: ‘Political theater’

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”